<VariationArchive VariationID="496985" VariationName="NM_000521.4(HEXB):c.1614-16_1615dup" VariationType="Duplication" Accession="VCV000496985" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-10" DateCreated="2018-04-02" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="488409" VariationID="496985">
      <GeneList>
        <Gene Symbol="HEXB" FullName="hexosaminidase subunit beta" GeneID="3074" HGNC_ID="HGNC:4879" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="74640023" stop="74721288" display_start="74640023" display_stop="74721288" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="73980968" stop="74017112" display_start="73980968" display_stop="74017112" Strand="+" />
          </Location>
          <OMIM>606873</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000521.4(HEXB):c.1614-16_1615dup</Name>
      <CanonicalSPDI>NC_000005.10:74721101:TTCATGTTATCTACAGAC:TTCATGTTATCTACAGACTTCATGTTATCTACAGAC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="74721101" stop="74721102" display_start="74721101" display_stop="74721102" variantLength="18" positionVCF="74721101" referenceAlleleVCF="A" alternateAlleleVCF="ATTCATGTTATCTACAGAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="74016926" stop="74016927" display_start="74016926" display_stop="74016927" variantLength="18" positionVCF="74016926" referenceAlleleVCF="A" alternateAlleleVCF="ATTCATGTTATCTACAGAC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.74721102_74721119dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.74721102_74721119dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.74016927_74016944dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.74016927_74016944dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009770.3" sequenceAccession="NG_009770" sequenceVersion="3" change="g.86081_86098dup">
            <Expression>NG_009770.3:g.86081_86098dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011531.1" sequenceAccession="NG_011531" sequenceVersion="1" change="g.51099_51116dup">
            <Expression>NG_011531.1:g.51099_51116dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001292004.2" sequenceAccession="NM_001292004" sequenceVersion="2" change="c.939-16_940dup">
            <Expression>NM_001292004.2:c.939-16_940dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000521.4" sequenceAccession="NM_000521" sequenceVersion="4" change="c.1614-16_1615dup" MANESelect="true">
            <Expression>NM_000521.4:c.1614-16_1615dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="606873.0003" DB="OMIM" />
        <XRef Type="rs" ID="1554037309" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000521.4(HEXB):c.1614-16_1615dup AND not provided" Accession="RCV000596163" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-10-06" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000521.4(HEXB):c.1614-16_1615dup AND Sandhoff disease" Accession="RCV000674261" Version="4">
        <ClassifiedConditionList TraitSetID="1058">
          <ClassifiedCondition DB="MedGen" ID="C0036161">Sandhoff disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-10-01" SubmissionCount="2">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000521.4(HEXB):c.1614-16_1615dup AND Hexosaminidase B (Paris)" Accession="RCV002286414" Version="1">
        <ClassifiedConditionList TraitSetID="1061">
          <ClassifiedCondition DB="MedGen" ID="C4016989">Hexosaminidase B (Paris)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1990-10-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-01" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-04-02" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">2170400</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">868875</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=HEXB</URL>
        </Citation>
        <DescriptionHistory Dated="2022-10-01">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-01">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1058" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4366" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Sandhoff disease</ElementValue>
                <XRef ID="Sandhoff+disease/6408" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010006" DB="MONDO" />
                <XRef ID="23849003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Beta-hexosaminidase-beta-subunit deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GM2 gangliosidosis, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Total hexosaminidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase A and B deficiency Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sandhoff-Jatzkewitz-Pilz disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GM2-GANGLIOSIDOSIS, TYPE II</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEXOSAMINIDASES A AND B DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Sandhoff disease comprises a phenotypic continuum encompassing acute infantile, subacute juvenile, and late-onset disease. Although classification into these phenotypes is somewhat arbitrary, it is helpful in understanding the variation observed in the timing of disease onset, presenting manifestations, rate of progression, and life span. Acute infantile Sandhoff disease (onset age &lt;6 months). Infants are generally normal at birth followed by progressive weakness and slowing of developmental progress, then developmental regression and severe neurologic impairment. Seizures are common. Death usually occurs between ages two and three years. Subacute juvenile Sandhoff disease (onset age 2-5 years). After attaining normal developmental milestones, developmental progress slows, followed by developmental regression and neurologic impairment (abnormal gait, dysarthria, and cognitive decline). Death (usually from aspiration) typically occurs in the early to late teens. Late-onset Sandhoff disease (onset older teen years or young adulthood). Nearly normal psychomotor development is followed by a range of neurologic findings (e.g., weakness, spasticity, dysarthria, and deficits in cerebellar function) and psychiatric findings (e.g., deficits in executive function and memory). Life expectancy is not necessarily decreased.</Attribute>
                <XRef ID="NBK579484" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2521" />
                <XRef ID="2521" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35420740</ID>
                <ID Source="BookShelf">NBK579484</ID>
              </Citation>
              <XRef ID="796" DB="Orphanet" />
              <XRef ID="C0036161" DB="MedGen" />
              <XRef ID="MONDO:0010006" DB="MONDO" />
              <XRef Type="MIM" ID="268800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1061" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10010" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hexosaminidase B (Paris)</ElementValue>
              </Name>
              <XRef ID="C4016989" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24246" SubmissionDate="2009-11-04" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606873.0003_HEXOSAMINIDASE B (PARIS)" title="HEXB, 18-BP INS_HEXOSAMINIDASE B (PARIS)" />
        <ClinVarAccession Accession="SCV000024246" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1990-10-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Dreyfus et al. (1977) characterized a hexosaminidase variant that may represent unstable beta subunits. Dlott et al. (1990) demonstrated that this so-called 'hexosaminidase Paris' had an abnormally elongated beta subunit due to duplication of a region straddling the junction of intron 13 and exon 14, which generated an alternate splice site and caused an in-frame insertion of 18 nucleotides into the mRNA. The normal splice site seemed to be used to some extent, accounting for the residual Hex-A isoenzyme activity.</Attribute>
              <Citation>
                <ID Source="PubMed">868875</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2170400</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXB" />
          </GeneList>
          <Name>HEXB, 18-BP INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">18-BP INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606873.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEXOSAMINIDASE B (PARIS)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1549871" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="590549|OMIM:268800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000799568" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2170400</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="5" alternateAllele="ATTCATGTTATCTACAGAC" referenceAllele="A" start="74016926" stop="74016926" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000521.3:c.1614-16_1615dup18</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="268800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1373358" SubmissionDate="2018-09-19" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="35939_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000700956" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXB" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="5" alternateAllele="TTCATGTTATCTACAGAC" referenceAllele="-" start="74016927" stop="74016944" variantLength="18" />
            <GeneLocation>NM_000521.3:IVS13</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=HEXB</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7064774" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="951533|MedGen:C0036161" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003784541" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2170400</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2170400</ID>
          </Citation>
          <Comment>This variant, c.1614-16_1615dup, results in the insertion of 6 amino acid(s) to the HEXB protein (p.Glu538_Arg539insLeuHisValIleTyrArg), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been observed in individual(s) with HEXB-related conditions (PMID: 2170400). This variant is also known as Hexosaminidase Paris. ClinVar contains an entry for this variant (Variation ID: 496985). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects HEXB function (PMID: 2170400). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.74016926_74016927insTTCATGTTATCTACAGAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0036161" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7064774" TraitType="Disease" MappingType="XRef" MappingValue="C0036161" MappingRef="MedGen">
        <MedGen CUI="C0036161" Name="Sandhoff disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24246" TraitType="Disease" MappingType="Name" MappingValue="HEXOSAMINIDASE B (PARIS)" MappingRef="Preferred">
        <MedGen CUI="C4016989" Name="Hexosaminidase B (Paris)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1549871" TraitType="Disease" MappingType="XRef" MappingValue="268800" MappingRef="OMIM">
        <MedGen CUI="C0036161" Name="Sandhoff disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1373358" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

